Statement of Cash Flows [Abstract] OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] NET LOSS Net Income (Loss) Attributable to Parent Adjustments to reconcile Net loss to Net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Inventory step-up Inventory Step Up Inventory Step Up Share-based compensation Share-based Compensation Amortization of debt issuance costs and discount Amortization of Debt Issuance Costs and Discounts Deferred income taxes Deferred Income Taxes and Tax Credits Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Asset impairment charges Asset Impairment Charges Gain on sale of business and other assets Gain (Loss) on Disposition of Business Changes in assets and liabilities which provided (used) cash: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable, accrued expenses and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income taxes payable/receivable Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property, plant and equipment, excluding capitalized interest Payments to Acquire Property, Plant, and Equipment Capitalized interest payments Interest Paid, Capitalized Proceeds from sale of business and other assets, net Proceeds from Divestiture of Businesses Other investing activities Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Principal payments on term loans Repayments of Other Long-term Debt Principal payments on other indebtedness Repayments of Debt Payments for contingent consideration Payment for Contingent Consideration Liability, Financing Activities Payments of tax withholding for restricted shares Payments Related to Tax Withholding for Share-based Compensation Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effect of foreign exchange rate Effect of Exchange Rate on Cash and Cash Equivalents Movement in cash held for sale Net Cash Provided by (Used in) Discontinued Operations NET INCREASE IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF PERIOD Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL INFORMATION: Supplemental Cash Flow Information [Abstract] Cash paid into Qualified Settlement Funds for mesh legal settlements Settlement Funds, Additions Settlement Funds, Additions Cash paid out of Qualified Settlement Funds for mesh legal settlements Settlement Funds, Payments Settlement Funds, Payments Other cash distributions for mesh legal settlements Other Payments For Legal Settlements Other Payments For Legal Settlements SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Accrual for purchases of property, plant and equipment Capital Expenditures Incurred but Not yet Paid Discontinued Operations and Disposal Groups [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Investment [Axis] Investment [Axis] Investment [Domain] Investment [Domain] Litha Joint Venture Investment Litha Joint Venture Investment [Member] Litha Joint Venture Investment [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] International Pharmaceuticals International Pharmaceuticals [Member] International Pharmaceuticals [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Litha Healthcare Group Limited Litha Healthcare Group Limited [Member] Litha Healthcare Group Limited [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Disposal Group, Held-for-sale, Not Discontinued Operations Disposal Group, Held-for-sale, Not Discontinued Operations [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Proceeds from sale of business, net Additional contingent consideration receivable Disposal Group, Including Discontinued Operation, Additional Contingent Consideration Receivable Disposal Group, Including Discontinued Operation, Additional Contingent Consideration Receivable Gain on sale of business Gain (Loss) on Disposition of Assets Additional contingent consideration payable Disposal Group, Including Discontinued Operation, Additional Contingent Consideration Payable Disposal Group, Including Discontinued Operation, Additional Contingent Consideration Payable Accrued Liabilities [Abstract] Schedule of accounts payable and accrued expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Income Statement [Abstract] TOTAL REVENUES Revenues COSTS AND EXPENSES: Costs and Expenses [Abstract] Cost of revenues Cost of Revenue Selling, general and administrative Selling, General and Administrative Expense Research and development Research and Development Expense Litigation-related and other contingencies, net Legal Fees Asset impairment charges Acquisition-related and integration items Business Combination, Acquisition Related Costs OPERATING LOSS FROM CONTINUING OPERATIONS Operating Income (Loss) INTEREST EXPENSE, NET Interest Income (Expense), Net OTHER INCOME, NET Nonoperating Income (Expense) LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAX Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest INCOME TAX EXPENSE (BENEFIT) Income Tax Expense (Benefit) LOSS FROM CONTINUING OPERATIONS Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest DISCONTINUED OPERATIONS, NET OF TAX (NOTE 3) Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest NET LOSS NET LOSS PER SHARE—BASIC: Earnings Per Share, Basic [Abstract] Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Basic (in dollars per share) Earnings Per Share, Basic NET LOSS PER SHARE—DILUTED: Earnings Per Share, Diluted [Abstract] Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Diluted (in dollars per share) Earnings Per Share, Diluted WEIGHTED AVERAGE SHARES: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (shares) Weighted Average Number of Shares Outstanding, Basic Diluted (shares) Weighted Average Number of Shares Outstanding, Diluted Component of Operating Income [Abstract] Schedule of components of other income, net Schedule of Other Nonoperating Income, by Component [Table Text Block] Foreign currency gain, net Foreign Currency Transaction Gain (Loss), before Tax Equity loss from investments accounted for under the equity method, net Income (Loss) from Equity Method Investments Other miscellaneous, net Other Nonoperating Income Other income, net Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Income Tax Disclosure [Abstract] Income tax expense (benefit) Total consolidated loss from continuing operations before income tax Provisional tax benefit related to Tax Cuts And Jobs Act Of 2017 Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount Subsequent Events [Abstract] Subsequent Events Subsequent Events, Policy [Policy Text Block] Inventory Disclosure [Abstract] INVENTORIES Inventory Disclosure [Text Block] DISCONTINUED OPERATIONS AND DIVESTITURES Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of disposal groups, including discontinued operations, income statement, balance sheet and additional disclosures Disposal Groups, Including Discontinued Operations [Table Text Block] Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 7.25% Senior Notes due 2022 Seven Point Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member] Seven Point Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member]. 5.75% Senior Notes due 2022 Five Point Seven Five Senior Notes Due On Two Thousand Twenty Two [Member] Five Point Seven Five Senior Notes Due On Two Thousand Twenty Two [Member] 5.375% Senior Notes due 2023 Five Point Three Seven Five Senior Notes Due On Two Thousand Twenty Three [Member] Five Point Three Seven Five Senior Notes Due On Two Thousand Twenty Three [Member] 6.00% Senior Notes due 2023 Six Point Zero Percent Senior Notes Due Two Thousand Twenty Three [Member] Six Point Zero Percent Senior Notes Due Two Thousand Twenty Three [Member] 5.875% Senior Secured Notes due 2024 Five Point Eight Seven Five Percent Senior Secured Notes Due Twenty Twenty Four [Member] Five Point Eight Seven Five Percent Senior Secured Notes Due Twenty Twenty Four [Member] 6.00% Senior Notes due 2025 6.00% Senior Notes Due 2025 [Member] 6.00% Senior Notes Due 2025 [Member] Term Loan B Facility Due 2024 Term Loan B Facility Due Two Thousand Twenty Four [Member] Term Loan B Facility Due Two Thousand Twenty Four [Member] Other debt Other Debt [Member] Other Debt [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Effective interest rate (as percent) Debt Instrument, Interest Rate, Effective Percentage Principal Amount Debt Instrument, Face Amount Carrying Amount Long-term Debt Less current portion, net Long-term Debt, Current Maturities Principal amount of total long-term debt, less current portion, net Debt Instrument, Face Amount, Excluding Current Maturities Debt Instrument, Face Amount, Excluding Current Maturities Carrying amount of total long-term debt, less current portion, net Long-term Debt, Excluding Current Maturities Interest rate (as percent) Debt Instrument, Interest Rate, Stated Percentage Fair value of long term debt Long-term Debt, Fair Value Goodwill and Intangible Assets Disclosure [Abstract] Amortization of intangible assets Amortization of Intangible Assets Schedule of new accounting pronouncements Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Equity [Abstract] Schedule of changes in stockholders' equity Schedule of Stockholders Equity [Table Text Block] Restructuring and Related Activities [Abstract] Schedule of restructuring reserve by type of cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] INCOME TAXES Income Tax Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-18 Accounting Standards Update 2016-18 [Member] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Prior to Adoption Scenario, Previously Reported [Member] Impact of Adoption Restatement Adjustment [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by operating activities Net cash used in investing activities Net cash used in financing activities Net change Cash and Cash Equivalents, Period Increase (Decrease) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Segment Reporting [Abstract] SEGMENT RESULTS Segment Reporting Disclosure [Text Block] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Decrease in restricted cash and cash equivalents Restricted Cash and Cash Equivalents Contract with Customer, Asset and Liability [Abstract] Contract Assets and Liabilities Revenue from Contract with Customer [Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Credit facility, remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Contract assets, net Contract with Customer, Asset, Net Contract assets, net - $ change Contract with Customer, Asset, Increase (Decrease) Contract with Customer, Asset, Increase (Decrease) Contract assets, net - % change Contract with Customer, Asset, Increase (Decrease), Percentage Contract with Customer, Asset, Increase (Decrease), Percentage Contract liabilities, net Contract with Customer, Liability Contract liabilities, net - $ change Contract with Customer, Liability, Increase (Decrease) Contract with Customer, Liability, Increase (Decrease) Contract liabilities, net - % change Contract with Customer, Liability, Increase (Decrease), Percentage Contract with Customer, Liability, Increase (Decrease), Percentage Contract asset amounts classified as current Contract with Customer, Asset, Net, Current Contract liability amounts classified as current Contract with Customer, Liability, Current Revenue recognized Contract with Customer, Liability, Revenue Recognized Reduction in revenue relating to performance obligation satisfied in prior periods Contract with Customer, Performance Obligation Satisfied in Previous Period Schedule of inventory Schedule of Inventory, Current [Table Text Block] Increase (Decrease) in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Shareholders' equity, beginning balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Effect of adopting ASC 606 Cumulative Effect of New Accounting Principle in Period of Adoption Shareholders' equity at January 1, 2018 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Compensation related to share-based awards Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Tax withholding for restricted shares Adjustments Related to Tax Withholding for Share-based Compensation Other Stockholders' Equity, Other Shareholders' equity, ending balance Commitments and Contingencies Disclosure [Abstract] Changes in Qualified Settlement Funds accounts and product liability balance Schedule of Loss Contingencies by Contingency [Table Text Block] DEBT Debt Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Money market funds Money Market Funds [Member] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Vaginal Mesh Cases Vaginal Mesh Cases [Member] Vaginal Mesh Cases [Member] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Restricted cash and cash equivalents Restricted Cash And Cash Equivalents [Member] Restricted Cash And Cash Equivalents [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Weighted Average Weighted Average [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Restricted cash and cash equivalents Restricted cash and cash equivalents classified as current assets Restricted Cash, Current Settlement funds Settlement Funds Settlement Funds Discount rate range (percent) Fair Value Inputs, Discount Rate Goodwill impairment charges Goodwill, Impairment Loss Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Accumulated Deficit Retained Earnings [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Amounts assuming continued application of ASC 605 Calculated under Revenue Guidance in Effect before Topic 606 [Member] Effect of adoption of ASC 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] ASC 606 Accounting Standards Update 2014-09 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Discount on brand-name drugs Discount On Brand Name Drugs Discount On Brand Name Drugs Decrease to accumulated deficit Statement of Operations: Loss from continuing operations Basic (in dollars per share) Net loss per share—Diluted: Diluted (in dollars per share) Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Inventories, net Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current OTHER ASSETS Other Assets, Noncurrent Liabilities: Liabilities [Abstract] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Shareholders' (deficit) equity: Statement of Stockholders' Equity [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) Schedule of Goodwill [Table] Schedule of Goodwill [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Intangible assets Intangible Assets [Member] Intangible Assets [Member] Developed technology Developed Technology Rights [Member] Former U.S. Generic Pharmaceuticals Former U.S. Generic Pharmaceuticals [Member] Former U.S. Generic Pharmaceuticals [Member] U.S. Branded - Sterile Injectables Branded Sterile Injectables [Member] Branded Sterile Injectables [Member] U.S. Generic Pharmaceuticals Generic Pharmaceuticals [Member] Generic Pharmaceuticals [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Paladin Labs Inc. Paladin Labs Inc. [Member] Paladin Labs Inc. [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Serelaxin In-Process Research and Development Intangible Assets Serelaxin In-Process Research and Development Intangible Assets [Member] Serelaxin In-Process Research and Development Intangible Assets [Member] Goodwill [Line Items] Goodwill [Line Items] Discount rate applied (percent) Goodwill impairment charges (reduction) Impairment of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Non-cash intangible asset impairment charge Impairment of Intangible Assets, Finite-lived Discontinued Operations, Disposed of by Sale Discontinued Operations, Disposed of by Sale [Member] Astora Astora [Member] Astora [Member] Litigation-related and other contingencies, net Disposal Group Including Discontinued Operation, Litigation Related And Other Contingencies Disposal Group Including Discontinued Operation, Litigation Related And Other Contingencies Loss from discontinued operations before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Income tax benefit Discontinued Operation, Tax Effect of Discontinued Operation Income (loss) from discontinued operations, net of tax Cash used in discontinued investing activities Operations Cash Provided by (Used in) Investing Activities, Discontinued Operations Depreciation and amortization Disposal Group, Including Discontinued Operation, Depreciation and Amortization Document And Entity Information [Abstract] Document and Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Ordinary Shares Outstanding Entity Common Stock, Shares Outstanding Trade accounts payable Accounts Payable, Trade, Current Returns and allowances Accrued Liabilities Returns And Allowances Accrued liabilities returns and allowances. Rebates Accrued Exchange Fee Rebate, Current Chargebacks Accrued Liabilities Chargebacks Accrued liabilities chargebacks. Accrued interest Interest Payable Accrued payroll and related benefits Accrued Payroll Taxes, Current Accrued royalties and other distribution partner payables Accrued Royalties and Other Distribution Partner Payables, Current Accrued Royalties and Other Distribution Partner Payables, Current Acquisition-related contingent consideration—short-term Business Combination, Contingent Consideration, Liability, Current Other Other Accrued Liabilities, Current Total Accrued Liabilities, Current Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Forecast Scenario, Forecast [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Corporate unallocated costs Segment Reconciling Items [Member] Operating Segments Operating Segments [Member] U.S. Branded - Specialty & Established Pharmaceuticals Branded Specialty and Established Pharmaceuticals [Member] Branded Specialty and Established Pharmaceuticals [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee Separation, Retention, and Other Benefit Related Costs Employee Separation, Retention, and Other Benefit Related Costs [Member] Employee Separation, Retention, and Other Benefit Related Costs [Member] Other restructuring charges Other Restructuring [Member] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] January 2018 Restructuring Initiative January 2018 Restructuring [Member] January 2018 Restructuring [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring and related cost, expected cost Restructuring and Related Cost, Expected Cost Restructuring estimated cash outlays Restructuring and Related Cost, Estimated Cash Payments Restructuring and Related Cost, Estimated Cash Payments Restructuring expenses Restructuring Charges Restructuring charges Restructuring Costs and Asset Impairment Charges Expected restructuring costs remaining Restructuring and Related Cost, Expected Cost Remaining Schedule of changes in the carrying amount of goodwill Schedule of Goodwill [Table Text Block] Schedule of other intangible assets Schedule Of Other Intangible Assets [Table Text Block] Schedule of other intangible assets table text block Schedule of future amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair value, measurements, nonrecurring Fair Value, Measurements, Nonrecurring [Member] Asset Class [Axis] Asset Class [Axis] Asset Class [Domain] Asset Class [Domain] Certain property, plant and equipment Property, Plant and Equipment [Member] 2017 US Generic Pharmaceuticals Restructuring US Generic Pharmaceuticals Restructuring 2017 [Member] US Generic Pharmaceuticals Restructuring 2017 [Member] Asset impairment charges Asset Impairment Charges [Member] Asset Impairment Charges [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Intangible assets, excluding goodwill Intangible Assets (Excluding Goodwill), Fair Value Disclosure Intangible Assets (Excluding Goodwill), Fair Value Disclosure Certain property, plant and equipment Property, Plant, and Equipment, Fair Value Disclosure Total Assets, Fair Value Disclosure Total expense for the year BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Acquisition-related contingent consideration Acquisition Related Contingent Consideration [Member] Acquisition-Related Contingent Consideration [Member] Auxilium acquisition Auxilium Pharmaceuticals, Inc. [Member] Auxilium Pharmaceuticals, Inc. [Member] Lehigh Valley Technologies, Inc. acquisitions Lehigh Valley Technologies, Inc. [Member] Lehigh Valley Technologies, Inc. [Member] VOLTAREN® Gel acquisition Voltaren Gel [Member] Voltaren Gel [Member] Other Other Acquisitions [Member] Other Acquisitions [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Beginning of period Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Amounts settled Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Changes in fair value recorded in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Effect of currency translation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Gain (Loss) Included in Other Comprehensive Income (Loss) Fair Value Adjustments and Accretion Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments And Accretion Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments And Accretion Payments and Other Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements And Effect Of Currency Translation Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements And Effect Of Currency Translation End of period ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Mesh Product Liability Accrual Product Liability [Member] Product Liability [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Qualified Settlement Funds Settlement Funds [Roll Forward] Settlement Funds [Roll Forward] Beginning balance Cash contributions to Qualified Settlement Funds Cash distributions to settle disputes from Qualified Settlement Funds Settlement Funds, Payments To Plaintiff Counsel From Qualified Settlement Funds Settlement Funds, Payments To Plaintiff Counsel From Qualified Settlement Funds Other Settlement Funds, Other Settlement Funds, Other Ending balance Mesh Liability Accrual Loss Contingency Accrual [Roll Forward] Beginning balance Loss Contingency Accrual Additional charges Loss Contingency Accrual, Provision Cash distributions to settle disputes from Qualified Settlement Funds Loss Contingency Accrual, Payments To Plaintiff Counsel From Qualified Settlement Funds Loss Contingency Accrual, Payments To Plaintiff Counsel From Qualified Settlement Funds Cash distributions to settle disputes Loss Contingency Accrual, Payments To Plaintiff Counsel Loss Contingency Accrual, Payments To Plaintiff Counsel Ending balance Employee separation, retention and other benefit-related costs Employee Severence and Other Benefit Related Costs [Member] Employee Severence and Other Benefit Related Costs [Member] Other Restructuring Costs Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Beginning liability balance Restructuring Reserve Expenses Cash distributions Payments for Restructuring Ending liability balance GOODWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Nonvested Restricted Stock Non Vested Restricted Stock [Member] Non Vested Restricted Stock [Member] Performance Stock Units Performance Stock Units [Member] Performance Stock Units [Member] Nonvested Stock Options Non Vested Stock Options [Member] Non Vested Stock Options [Member] Plan Scenario, Plan [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based compensation awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Stock options issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Awarded in Period, Not Yet Granted, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Awarded in Period, Not Yet Granted, Gross Target amount of share-based compensation awards (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Awarded in Period, Not Yet Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Awarded in Period, Not Yet Granted Award fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average remaining requisite service period, non-vested restricted stock units Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Earnings Per Share [Abstract] Numerator: Earnings Per Share Reconciliation [Abstract] Loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Loss from discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] For basic per share data—weighted average shares (shares) Dilutive effect of ordinary share equivalents (shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Dilutive effect of various convertible notes and warrants Dilutive Effect Of Convertible Senior Subordinated Notes And Warrants Dilutive Effect Of Convertible Senior Subordinated Notes And Warrants For diluted per share data—weighted average shares (shares) Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total Long-term inventory Inventory, Noncurrent Inventories not yet available for sale Inventory, Not Yet Available For Sale, Net Inventory, Not Yet Available For Sale, Net Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] XIAFLEX® Xiaflex [Member] Xiaflex [Member] SUPPRELIN® LA SUPPRELIN LA [Member] SUPPRELIN LA [Member] Other Specialty Other Specialty Products [Member] Other Specialty Products [Member] Total Specialty Products Total Specialty Products [Member] Total Specialty Products [Member] PERCOCET® PERCOCET [Member] PERCOCET [Member] VOLTAREN® Gel OPANA® ER Opana [Member] Opana [Member] Other Established Other Established Products [Member] Other Established Products [Member] Total Established Products Established Products [Member] Established Products [Member] Vasostrict® Vasostrict [Member] Vasostrict [Member] ADRENALIN® Adrenalin [Member] Adrenalin [Member] Other Sterile Injectables Other Sterile Injectables [Member] Other Sterile Injectables [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Product line revenue reporting threshold Product Line Revenue Reporting Threshold Product Line Revenue Reporting Threshold Concentration risk, percentage Concentration Risk, Percentage CURRENT ASSETS: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Restricted cash and cash equivalents Accounts receivable Accounts Receivable, Net, Current Prepaid expenses and other current assets Income taxes receivable Income Taxes Receivable, Current Total current assets Assets, Current MARKETABLE SECURITIES Marketable Securities, Noncurrent PROPERTY, PLANT AND EQUIPMENT, NET Property, Plant and Equipment, Net GOODWILL Goodwill OTHER INTANGIBLES, NET Intangible Assets, Net (Excluding Goodwill) DEFERRED INCOME TAXES Deferred Income Tax Assets, Net TOTAL ASSETS Assets LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY Liabilities and Equity [Abstract] CURRENT LIABILITIES: Liabilities, Current [Abstract] Accounts payable and accrued expenses Current portion of legal settlement accrual Loss Contingency, Accrual, Current Current portion of long-term debt Income taxes payable Accrued Income Taxes, Current Total current liabilities Liabilities, Current DEFERRED INCOME TAXES Deferred Income Tax Liabilities, Net LONG-TERM DEBT, LESS CURRENT PORTION, NET LONG-TERM LEGAL SETTLEMENT ACCRUAL, LESS CURRENT PORTION Loss Contingency, Accrual, Noncurrent OTHER LIABILITIES Other Liabilities, Noncurrent COMMITMENTS AND CONTINGENCIES (NOTE 12) Commitments and Contingencies SHAREHOLDERS' (DEFICIT) EQUITY: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Euro deferred shares, $0.01 par value; 4,000,000 shares authorized and issued at both March 31, 2018 and December 31, 2017 Euro Deferred Stock, Value, Issued Euro Deferred Stock, Value, Issued Ordinary shares, $0.0001 par value; 1,000,000,000 shares authorized; 223,783,675 and 223,331,706 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total shareholders' (deficit) equity TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY Liabilities and Equity FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] January 2017 Restructuring January 2017 Restructuring [Member] January 2017 Restructuring [Member] Accelerated Depreciation Accelerated Depreciation [Member] Accelerated Depreciation [Member] Asset Impairment Charges U.S. Branded - Specialty & Established Pharmaceuticals Branded Pharmaceuticals [Member] Branded Pharmaceuticals [Member] Expected number of positions to be eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Schedule of Goodwill And Other Intangibles [Table] Schedule of Goodwill And Other Intangibles [Table] Schedule of Goodwill and Other Intangibles [Table]. Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Licenses Licensing Agreements [Member] Tradenames Trade Names [Member] Other Intangible Assets [Line Items] Other Intangible Assets [Line Items] Other Intangible Assets [Line Items] Cost basis: Other Intangible Assets, Cost Basis [Abstract] Other Intangible Assets, Cost Basis [Abstract] Indefinite-lived intangibles: Indefinite-lived Intangible Assets [Roll Forward] Beginning Balance Indefinite-Lived Intangible Assets (Excluding Goodwill) Acquisitions Indefinite-lived Intangible Assets Acquired Impairments Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Effect of Currency Translation Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss) Ending Balance Finite-lived intangibles: Finite-lived Intangible Assets [Roll Forward] Beginning Balance Finite-Lived Intangible Assets, Gross Acquisitions Finite-lived Intangible Assets Acquired Impairments Effect of Currency Translation Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Ending Balance Total other intangibles Intangible Assets, Gross [Roll Forward] Intangible Assets, Gross [Roll Forward] Beginning balance Intangible Assets, Gross (Excluding Goodwill) Acquisitions Intangible Assets Acquired Intangible Assets Acquired Impairments Effect of Currency Translation Intangible Assets, Foreign Currency Translation Gain (Loss) Intangible Assets, Foreign Currency Translation Gain (Loss) Ending balance Accumulated amortization: Finite-Lived Intangible Assets, Accumulated Amortization [Roll Forward] Finite-Lived Intangible Assets, Accumulated Amortization [Roll Forward] Beginning Balance Finite-Lived Intangible Assets, Accumulated Amortization Amortization Impairments Impairment of Intangible Assets, Finite-lived, Effect On Accumulated Amortization Impairment of Intangible Assets, Finite-lived, Effect On Accumulated Amortization Effect of Currency Translation Finite-Lived Intangible Assets, Translation Adjustments, Effect On Accumulated Amortization Finite-Lived Intangible Assets, Translation Adjustments, Effect On Accumulated Amortization Ending Balance Net other intangibles Intangible life (years) Finite-Lived Intangible Asset, Useful Life Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Number of reportable segments Number of Reportable Segments Total net revenues from external customers Total segment adjusted income from continuing operations before income tax Adjusted Income (Loss) Before Income Tax Adjusted income (loss) before income tax. Statement of Comprehensive Income [Abstract] OTHER COMPREHENSIVE (LOSS) INCOME: Other Comprehensive Income (Loss), Net of Tax [Abstract] Net unrealized gain (loss) on securities, net of tax: Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax [Abstract] Unrealized gain (loss) arising during the period Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Less: reclassification adjustments for gain realized in net loss Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Net unrealized gain (loss) on securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Net unrealized (loss) gain on foreign currency: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract] Foreign currency translation (loss) gain arising during the period Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Less: reclassification adjustments for loss realized in net loss Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Foreign currency translation gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax OTHER COMPREHENSIVE (LOSS) INCOME COMPREHENSIVE LOSS Comprehensive Income (Loss), Net of Tax, Attributable to Parent Reconciliation of the numerator and denominator of basic and diluted net loss per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] OTHER INCOME, NET Other Income and Other Expense Disclosure [Text Block] 2018 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Five Shareholders' (Deficit) Equity Stockholders' Equity Note Disclosure [Text Block] Financial assets and liabilities measured at fair value on recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Changes to liability for acquisition-related contingent consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of nonrecurring fair value measurements Fair Value Measurements, Nonrecurring [Table Text Block] Contract Assets and Liabilities Contract with Customer, Asset and Liability [Table Text Block] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] OTHER COMPREHENSIVE (LOSS) INCOME Comprehensive Income (Loss) Note [Text Block] Subsequent Event [Table] Subsequent Event [Table] Somerset Somerset Therapeutics, LLC [Member] Somerset Therapeutics, LLC [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Interest to be acquired (percent) Business Acquisition, Percentage of Voting Interests Acquired Cash purchase price Business Combination, Consideration Transferred Debt to be assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Accumulated impairment losses Goodwill, Impaired, Accumulated Impairment Loss RESTRUCTURING Restructuring and Related Activities Disclosure [Text Block] Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Judicial Ruling Judicial Ruling [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] AMS American Medical Systems [Member] American Medical Systems [Member] Par Pharmaceutical, Inc. Par Pharmaceutical, Inc. [Member] Par Pharmaceutical, Inc. [Member] Endo Pharmaceuticals Inc. Endo Pharmaceuticals Inc. [Member] Endo Pharmaceuticals Inc. [Member] Testosterone Cases Testosterone Cases [Member] Testosterone Cases [Member] Unapproved Drug Litigation Unapproved Drug Litigation [Member] Unapproved Drug Litigation [Member] Opioid-Related Matters Opioid-Related Matters [Member] Opioid-Related Matters [Member] Pricing Matters Cases Pricing Matters Cases [Member] Pricing Matters Cases [Member] Lidoderm cases Lidoderm [Member] Lidoderm [Member] Bier v. Endo International plc, et al. Bier v. Endo International plc, et al. [Member] Bier v. Endo International plc, et al. [Member] VASOSTRICT Related Matters VASOSTRICT Related Matters [Member] VASOSTRICT Related Matters [Member] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Current and Former Directors and Officers Current and Former Directors and Officers [Member] Current and Former Directors and Officers [Member] Tranche [Axis] Tranche [Axis] Tranche [Axis] Tranche [Domain] Tranche [Domain] [Domain] for Tranche [Axis] First tranche Tranche 1 [Member] Tranche 1 [Member] Reserve for loss contingencies Product liability accrual, period expense Loss Contingency Accrual, Product Liability, Gross Increase in legal reserves Loss Contingency Accrual, Period Increase (Decrease) Loss contingency, claims settled, number Loss Contingency, Claims Settled, Number Payments to plaintiffs and qualified settlement funds Loss Contingency Accrual, Payments Pending claims, number Loss Contingency, Pending Claims, Number Number of cases filed by states Loss Contingency, Claims Filed By States, Number Loss Contingency, Claims Filed By States, Number Number of cases filed by hospitals, health systems, unions, welfare funds or other third-party Loss Contingency, Number Of Cases Filed By Hospitals, Health Systems, Unions, Welfare Funds Or Other Third-Party Loss Contingency, Number Of Cases Filed By Hospitals, Health Systems, Unions, Welfare Funds Or Other Third-Party Number of cases alleging personal injury and/or wrongful death Loss Contingency, Number Of Cases Alleging Personal Injury And/Or Wrongful Death Loss Contingency, Number Of Cases Alleging Personal Injury And/Or Wrongful Death Number of claims set for trial Loss Contingency, Cases Set For Trial, Number Loss Contingency, Cases Set For Trial, Number Number of products involved in claims Loss Contingency, Number of Products Involved in Claims Loss Contingency, Number of Products Involved in Claims Number of tranches for claims Loss Contingency, Number of Tranches for Claims Loss Contingency, Number of Tranches for Claims Number of state attorney generals State Attorney Generals, Number State Attorney Generals, Number Number of claims consolidated Loss Contingency, Number of Claims Consolidated Loss Contingency, Number of Claims Consolidated Number of defendants Loss Contingency, Number of Defendants Number of products allegedly manufactured by PPI Loss Contingency, Number Of Products Allegedly Manufactured By PPI Loss Contingency, Number Of Products Allegedly Manufactured By PPI Number of additional defendants Loss Contingency, Number Of Additional Defendants Named Loss Contingency, Number Of Additional Defendants Named Number of patents allegedly infringed upon Gain Contingency, Patents Allegedly Infringed upon, Number Number of defendants filing motion to dismiss for lack of personal injury jurisdiction Loss Contingency, Number Of Defendants Filing Motion To Dismiss, Lack Of Personal Injury Jurisdiction Loss Contingency, Number Of Defendants Filing Motion To Dismiss, Lack Of Personal Injury Jurisdiction Number of defendants filing motion to dismiss the breach of contract claim Loss Contingency, Number Of Defendants Filing Motion To Dismiss Loss Contingency, Number Of Defendants Filing Motion To Dismiss Stay of litigation, number of days Loss Contingency, Stay Of Proceedings, Number Of Days Loss Contingency, Stay Of Proceedings, Number Of Days Number of patents found infringed upon Gain Contingency, Patents Found Infringed upon, Number Period for generic product to be withdrawn Gain Contingency, Period For Withdrawing Generic Product Gain Contingency, Period For Withdrawing Generic Product Number of post-trial motions Gain Contingency, Number Of Post-Trial Motions Gain Contingency, Number Of Post-Trial Motions Settlement awarded Litigation Settlement, Amount Awarded from Other Party Lawsuit filing period Loss Contingency, Lawsuit Filing Period Loss Contingency, Lawsuit Filing Period Stay of approval period, hatch-waxman act Loss Contingency, Stay Of Approval Period, Hatch-Waxman Act Loss Contingency, Stay Of Approval Period, Hatch-Waxman Act Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning balance Allocation to current segments Goodwill, Allocation To Current Segments Goodwill, Allocation To Current Segments Effect of currency translation on gross balance Goodwill, Foreign Currency Translation Gain (Loss) Goodwill impairment charges Goodwill, ending balance Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Recent Accounting Pronouncements Recent Accounting Pronouncements [Policy Text Block] Recent Accounting Pronouncements [Text Block] Schedule of long-term debt instruments Schedule of Long-term Debt Instruments [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Net unrealized gain (loss) on securities Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Net unrealized gain (loss) on foreign currency Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Before Reclassification, Before Tax Amount Other Comprehensive Income (Loss), before Reclassifications, before Tax Before Reclassification, Tax Benefit (Expense) Other Comprehensive Income (Loss) before Reclassifications, Tax Before Reclassification, Net-of-Tax Amount Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Reclassification, Before Tax Amount Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Reclassification, Tax Benefit (Expense) Reclassification from AOCI, Current Period, Tax Reclassification, Net-of-Tax Amount Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Before- Tax Amount Other Comprehensive Income (Loss), before Tax Tax Benefit (Expense) Other Comprehensive Income (Loss), Tax Segment Reconciling Items Inventory Write-Offs Inventory Write-Offs [Member] Inventory Write-Offs [Member] Interest expense, net Corporate unallocated costs Segment Reporting Information, Unallocated Corporate Expense Segment Reporting Information, Unallocated Corporate Expense Amortization of intangible assets Upfront and milestone payments to partners Upfront And Milestone Payments To Partners Upfront and milestone payments to partners. Separation benefits and other cost reduction initiatives Cost Reduction Initiatives Cost Reduction Initiatives Certain litigation-related and other contingencies, net Loss Contingency, Loss in Period Acquisition-related costs Foreign currency impact related to the remeasurement of intercompany debt instruments Adjustment for Long-term Intercompany Transactions, Gross of Tax Other, net Other Nonrecurring (Income) Expense Severance costs Severance Costs Accelerated depreciation Restructuring and Related Cost, Accelerated Depreciation Change in fair value of contingent consideration Transaction costs Business Combination, Closing Transaction Costs Business Combination, Closing Transaction Costs NET LOSS PER SHARE Earnings Per Share [Text Block] Somar Somar [Member] Somar [Member] Aggregate purchase price Disposal Group, Including Discontinued Operation, Consideration Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis] Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain] Time deposits Bank Time Deposits [Member] Equity securities Equity Securities [Member] Acquisition-related contingent consideration—short-term Acquisition Related Contingent Consideration Short Term [Member] Acquisition Related Contingent Consideration-Short Term [Member] Acquisition-related contingent consideration—long-term Acquisition Related Contingent Consideration Long Term [Member] Acquisition-Related Contingent Consideration-Long Term [Member] Assets: Fair value of financial assets measured on recurring basis Assets, Fair Value Disclosure, Recurring Fair value of financial liabilities measured on recurring basis Liabilities, Fair Value Disclosure, Recurring Schedule of reportable segments information Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of reconciliations of consolidated loss from continuing operations before income tax Schedule Of Reconciliations Of Consolidated Adjusted Income (Loss) Before Income Tax To Consolidated Income Before Income Tax [Table Text Block] Schedule Of Reconciliations Of Consolidated Adjusted Income (Loss) Before Income Tax To Consolidated Income Before Income Tax [Table Text Block] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Euro deferred shares, par value (in dollars per share) Euro Deferred Shares, Par or Stated Value Per Share Euro Deferred Shares, Par or Stated Value Per Share Euro deferred shares, shares authorized Euro Deferred Shares, Shares Authorized Euro Deferred Shares, Shares Authorized Euro deferred shares, shares issued Euro Deferred Shares, Shares Issued Euro Deferred Shares, Shares Issued Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Schedule of tax effects allocated to each component of other comprehensive income Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]